Report Detail

Pharma & Healthcare Global Felodipine Sustained-Release Tablet Sales Market Report 2021

  • RnM4227846
  • |
  • 23 June, 2021
  • |
  • Global
  • |
  • 132 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Felodipine sustained-release tablets are used to treat hypertension and stable angina pectoris.

Market Analysis and Insights: Global Felodipine Sustained-Release Tablet Market
The global Felodipine Sustained-Release Tablet market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Felodipine Sustained-Release Tablet Scope and Market Size
The global Felodipine Sustained-Release Tablet market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Felodipine Sustained-Release Tablet market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
2.5mg Per Tablet
5mg Per Tablet
Others

Segment by Application
Treat High Blood Pressure
Relieve Angina
Others

The Felodipine Sustained-Release Tablet market is analysed and market size information is provided by regions (countries). Segment by Application, the Felodipine Sustained-Release Tablet market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Astrazeneca
NanJing Easeheal Phaemaecutical
SHANXI KANGBO BIOLOGICAL PRODUCT
Lifeon
Changzhou Siyao Pharmaceutical
Mylan
Sandoz


1 Felodipine Sustained-Release Tablet Market Overview

  • 1.1 Felodipine Sustained-Release Tablet Product Scope
  • 1.2 Felodipine Sustained-Release Tablet Segment by Type
    • 1.2.1 Global Felodipine Sustained-Release Tablet Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 2.5mg Per Tablet
    • 1.2.3 5mg Per Tablet
    • 1.2.4 Others
  • 1.3 Felodipine Sustained-Release Tablet Segment by Application
    • 1.3.1 Global Felodipine Sustained-Release Tablet Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Treat High Blood Pressure
    • 1.3.3 Relieve Angina
    • 1.3.4 Others
  • 1.4 Felodipine Sustained-Release Tablet Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Felodipine Sustained-Release Tablet Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Felodipine Sustained-Release Tablet Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Felodipine Sustained-Release Tablet Price Trends (2016-2027)

2 Felodipine Sustained-Release Tablet Estimates and Forecasts by Region

  • 2.1 Global Felodipine Sustained-Release Tablet Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Felodipine Sustained-Release Tablet Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Felodipine Sustained-Release Tablet Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Felodipine Sustained-Release Tablet Revenue Market Share by Region (2016-2021)
  • 2.3 Global Felodipine Sustained-Release Tablet Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Felodipine Sustained-Release Tablet Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Felodipine Sustained-Release Tablet Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Felodipine Sustained-Release Tablet Estimates and Projections (2016-2027)
    • 2.4.2 Europe Felodipine Sustained-Release Tablet Estimates and Projections (2016-2027)
    • 2.4.3 China Felodipine Sustained-Release Tablet Estimates and Projections (2016-2027)
    • 2.4.4 Japan Felodipine Sustained-Release Tablet Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Felodipine Sustained-Release Tablet Estimates and Projections (2016-2027)
    • 2.4.6 India Felodipine Sustained-Release Tablet Estimates and Projections (2016-2027)

3 Global Felodipine Sustained-Release Tablet Competition Landscape by Players

  • 3.1 Global Top Felodipine Sustained-Release Tablet Players by Sales (2016-2021)
  • 3.2 Global Top Felodipine Sustained-Release Tablet Players by Revenue (2016-2021)
  • 3.3 Global Felodipine Sustained-Release Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Felodipine Sustained-Release Tablet as of 2020)
  • 3.4 Global Felodipine Sustained-Release Tablet Average Price by Company (2016-2021)
  • 3.5 Manufacturers Felodipine Sustained-Release Tablet Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Felodipine Sustained-Release Tablet Market Size by Type

  • 4.1 Global Felodipine Sustained-Release Tablet Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Felodipine Sustained-Release Tablet Price by Type (2016-2021)
  • 4.2 Global Felodipine Sustained-Release Tablet Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Felodipine Sustained-Release Tablet Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Felodipine Sustained-Release Tablet Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Felodipine Sustained-Release Tablet Price Forecast by Type (2022-2027)

5 Global Felodipine Sustained-Release Tablet Market Size by Application

  • 5.1 Global Felodipine Sustained-Release Tablet Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Felodipine Sustained-Release Tablet Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Felodipine Sustained-Release Tablet Price by Application (2016-2021)
  • 5.2 Global Felodipine Sustained-Release Tablet Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Felodipine Sustained-Release Tablet Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Felodipine Sustained-Release Tablet Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Felodipine Sustained-Release Tablet Price Forecast by Application (2022-2027)

6 North America Felodipine Sustained-Release Tablet Market Facts & Figures

  • 6.1 North America Felodipine Sustained-Release Tablet Sales by Company
    • 6.1.1 North America Felodipine Sustained-Release Tablet Sales by Company (2016-2021)
    • 6.1.2 North America Felodipine Sustained-Release Tablet Revenue by Company (2016-2021)
  • 6.2 North America Felodipine Sustained-Release Tablet Sales Breakdown by Type
    • 6.2.1 North America Felodipine Sustained-Release Tablet Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Felodipine Sustained-Release Tablet Sales Breakdown by Type (2022-2027)
  • 6.3 North America Felodipine Sustained-Release Tablet Sales Breakdown by Application
    • 6.3.1 North America Felodipine Sustained-Release Tablet Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Felodipine Sustained-Release Tablet Sales Breakdown by Application (2022-2027)

7 Europe Felodipine Sustained-Release Tablet Market Facts & Figures

  • 7.1 Europe Felodipine Sustained-Release Tablet Sales by Company
    • 7.1.1 Europe Felodipine Sustained-Release Tablet Sales by Company (2016-2021)
    • 7.1.2 Europe Felodipine Sustained-Release Tablet Revenue by Company (2016-2021)
  • 7.2 Europe Felodipine Sustained-Release Tablet Sales Breakdown by Type
    • 7.2.1 Europe Felodipine Sustained-Release Tablet Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Felodipine Sustained-Release Tablet Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Felodipine Sustained-Release Tablet Sales Breakdown by Application
    • 7.3.1 Europe 132 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 132 Sales Breakdown by Application (2022-2027)

8 China Felodipine Sustained-Release Tablet Market Facts & Figures

  • 8.1 China Felodipine Sustained-Release Tablet Sales by Company
    • 8.1.1 China Felodipine Sustained-Release Tablet Sales by Company (2016-2021)
    • 8.1.2 China Felodipine Sustained-Release Tablet Revenue by Company (2016-2021)
  • 8.2 China Felodipine Sustained-Release Tablet Sales Breakdown by Type
    • 8.2.1 China Felodipine Sustained-Release Tablet Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Felodipine Sustained-Release Tablet Sales Breakdown by Type (2022-2027)
  • 8.3 China Felodipine Sustained-Release Tablet Sales Breakdown by Application
    • 8.3.1 China 240 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 240 Sales Breakdown by Application (2022-2027)

9 Japan Felodipine Sustained-Release Tablet Market Facts & Figures

  • 9.1 Japan Felodipine Sustained-Release Tablet Sales by Company
    • 9.1.1 Japan Felodipine Sustained-Release Tablet Sales by Company (2016-2021)
    • 9.1.2 Japan Felodipine Sustained-Release Tablet Revenue by Company (2016-2021)
  • 9.2 Japan Felodipine Sustained-Release Tablet Sales Breakdown by Type
    • 9.2.1 Japan Felodipine Sustained-Release Tablet Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Felodipine Sustained-Release Tablet Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Felodipine Sustained-Release Tablet Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Felodipine Sustained-Release Tablet Market Facts & Figures

  • 10.1 Southeast Asia Felodipine Sustained-Release Tablet Sales by Company
    • 10.1.1 Southeast Asia Felodipine Sustained-Release Tablet Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Felodipine Sustained-Release Tablet Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Felodipine Sustained-Release Tablet Sales Breakdown by Type
    • 10.2.1 Southeast Asia Felodipine Sustained-Release Tablet Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Felodipine Sustained-Release Tablet Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Felodipine Sustained-Release Tablet Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Felodipine Sustained-Release Tablet Market Facts & Figures

  • 11.1 India Felodipine Sustained-Release Tablet Sales by Company
    • 11.1.1 India Felodipine Sustained-Release Tablet Sales by Company (2016-2021)
    • 11.1.2 India Felodipine Sustained-Release Tablet Revenue by Company (2016-2021)
  • 11.2 India Felodipine Sustained-Release Tablet Sales Breakdown by Type
    • 11.2.1 India Felodipine Sustained-Release Tablet Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Felodipine Sustained-Release Tablet Sales Breakdown by Type (2022-2027)
  • 11.3 India Felodipine Sustained-Release Tablet Sales Breakdown by Application
    • 11.3.1 India Felodipine Sustained-Release Tablet Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Felodipine Sustained-Release Tablet Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Felodipine Sustained-Release Tablet Business

  • 12.1 Astrazeneca
    • 12.1.1 Astrazeneca Corporation Information
    • 12.1.2 Astrazeneca Business Overview
    • 12.1.3 Astrazeneca Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Astrazeneca Felodipine Sustained-Release Tablet Products Offered
    • 12.1.5 Astrazeneca Recent Development
  • 12.2 NanJing Easeheal Phaemaecutical
    • 12.2.1 NanJing Easeheal Phaemaecutical Corporation Information
    • 12.2.2 NanJing Easeheal Phaemaecutical Business Overview
    • 12.2.3 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Products Offered
    • 12.2.5 NanJing Easeheal Phaemaecutical Recent Development
  • 12.3 SHANXI KANGBO BIOLOGICAL PRODUCT
    • 12.3.1 SHANXI KANGBO BIOLOGICAL PRODUCT Corporation Information
    • 12.3.2 SHANXI KANGBO BIOLOGICAL PRODUCT Business Overview
    • 12.3.3 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Products Offered
    • 12.3.5 SHANXI KANGBO BIOLOGICAL PRODUCT Recent Development
  • 12.4 Lifeon
    • 12.4.1 Lifeon Corporation Information
    • 12.4.2 Lifeon Business Overview
    • 12.4.3 Lifeon Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Lifeon Felodipine Sustained-Release Tablet Products Offered
    • 12.4.5 Lifeon Recent Development
  • 12.5 Changzhou Siyao Pharmaceutical
    • 12.5.1 Changzhou Siyao Pharmaceutical Corporation Information
    • 12.5.2 Changzhou Siyao Pharmaceutical Business Overview
    • 12.5.3 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Products Offered
    • 12.5.5 Changzhou Siyao Pharmaceutical Recent Development
  • 12.6 Mylan
    • 12.6.1 Mylan Corporation Information
    • 12.6.2 Mylan Business Overview
    • 12.6.3 Mylan Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Mylan Felodipine Sustained-Release Tablet Products Offered
    • 12.6.5 Mylan Recent Development
  • 12.7 Sandoz
    • 12.7.1 Sandoz Corporation Information
    • 12.7.2 Sandoz Business Overview
    • 12.7.3 Sandoz Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Sandoz Felodipine Sustained-Release Tablet Products Offered
    • 12.7.5 Sandoz Recent Development

...

    13 Felodipine Sustained-Release Tablet Manufacturing Cost Analysis

    • 13.1 Felodipine Sustained-Release Tablet Key Raw Materials Analysis
      • 13.1.1 Key Raw Materials
      • 13.1.2 Key Raw Materials Price Trend
      • 13.1.3 Key Suppliers of Raw Materials
    • 13.2 Proportion of Manufacturing Cost Structure
    • 13.3 Manufacturing Process Analysis of Felodipine Sustained-Release Tablet
    • 13.4 Felodipine Sustained-Release Tablet Industrial Chain Analysis

    14 Marketing Channel, Distributors and Customers

    • 14.1 Marketing Channel
    • 14.2 Felodipine Sustained-Release Tablet Distributors List
    • 14.3 Felodipine Sustained-Release Tablet Customers

    15 Market Dynamics

    • 15.1 Felodipine Sustained-Release Tablet Market Trends
    • 15.2 Felodipine Sustained-Release Tablet Drivers
    • 15.3 Felodipine Sustained-Release Tablet Market Challenges
    • 15.4 Felodipine Sustained-Release Tablet Market Restraints

    16 Research Findings and Conclusion

      17 Appendix

      • 17.1 Research Methodology
        • 17.1.1 Methodology/Research Approach
        • 17.1.2 Data Source
      • 17.2 Author List

      Summary:
      Get latest Market Research Reports on Felodipine Sustained-Release Tablet. Industry analysis & Market Report on Felodipine Sustained-Release Tablet is a syndicated market report, published as Global Felodipine Sustained-Release Tablet Sales Market Report 2021. It is complete Research Study and Industry Analysis of Felodipine Sustained-Release Tablet market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,000.00
      $6,000.00
      $8,000.00
      3,192.00
      4,788.00
      6,384.00
      3,732.00
      5,598.00
      7,464.00
      615,040.00
      922,560.00
      1,230,080.00
      333,840.00
      500,760.00
      667,680.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report